GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Nhu Co Ltd (SZSE:002001) » Definitions » Capex-to-Revenue

Zhejiang Nhu Co (SZSE:002001) Capex-to-Revenue : 0.05 (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Nhu Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Zhejiang Nhu Co's Capital Expenditure for the three months ended in Jun. 2024 was ¥-253.50 Mil. Its Revenue for the three months ended in Jun. 2024 was ¥5,345.95 Mil.

Hence, Zhejiang Nhu Co's Capex-to-Revenue for the three months ended in Jun. 2024 was 0.05.


Zhejiang Nhu Co Capex-to-Revenue Historical Data

The historical data trend for Zhejiang Nhu Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Nhu Co Capex-to-Revenue Chart

Zhejiang Nhu Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.23 0.23 0.31 0.29

Zhejiang Nhu Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.27 0.27 0.13 0.05

Competitive Comparison of Zhejiang Nhu Co's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Nhu Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zhejiang Nhu Co's Capex-to-Revenue falls into.



Zhejiang Nhu Co Capex-to-Revenue Calculation

Zhejiang Nhu Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4445.522) / 15116.537
=0.29

Zhejiang Nhu Co's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-253.496) / 5345.948
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Nhu Co  (SZSE:002001) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Zhejiang Nhu Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zhejiang Nhu Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Nhu Co Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Jiangbei Road, Yulin Street, Xinchang County, Zhejiang Province, Shaoxing, CHN, 312500
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer and Anti-bacterial with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3 and coenzyme Q10 and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
Executives
Hu Bai Fan Director
Shi Guan Qun Directors, Directors, and Executives
Hu Bai Shan Directors, executives
Cui Xin Rong Director
Chen Xue Cao Supervisors
Zhou Gui Yang Director
Qiu Jin Zhuo Supervisors
Wang Xue Wen Directors, executives
Wang Zheng Jiang Director
Ye Yue Heng Director
Dong Xiao Fang Supervisors
Liang Xiao Dong Supervisors
Zhang Xiao Bo Supervisors
Wang Xu Lin Supervisors
Ding Zhong Jun Director

Zhejiang Nhu Co Headlines

No Headlines